Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1916 1
1922 1
1927 1
1938 1
1940 1
1944 1
1945 1
1946 2
1947 2
1948 2
1951 1
1953 1
1954 2
1955 1
1956 1
1958 1
1961 1
1963 2
1964 3
1965 1
1966 3
1967 9
1968 4
1969 3
1970 1
1971 2
1972 5
1973 1
1975 1
1978 1
1979 1
1981 3
1983 1
1984 4
1985 1
1986 2
1987 3
1988 4
1989 8
1990 1
1991 5
1992 5
1993 3
1994 3
1995 4
1996 1
1997 3
1998 4
1999 6
2000 3
2001 4
2002 7
2003 8
2004 7
2005 6
2006 8
2007 9
2008 10
2009 12
2010 13
2011 11
2012 10
2013 11
2014 8
2015 10
2016 7
2017 9
2018 7
2019 11
2020 10
2021 13
2022 10
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

323 results

Results by year

Filters applied: . Clear all
Page 1
Initial Management of Seizure in Adults.
Smith PEM. Smith PEM. N Engl J Med. 2021 Jul 15;385(3):251-263. doi: 10.1056/NEJMcp2024526. N Engl J Med. 2021. PMID: 34260837 Review. No abstract available.
Editors' commentary.
Fuller GN, Smith PEM. Fuller GN, et al. Among authors: smith pem. Pract Neurol. 2023 Nov 23;23(6):461. doi: 10.1136/pn-2023-004008. Pract Neurol. 2023. PMID: 37996108 No abstract available.
Editors' commentary.
Smith PEM, Fuller GN. Smith PEM, et al. Pract Neurol. 2023 Jun;23(3):189. doi: 10.1136/pn-2023-003794. Pract Neurol. 2023. PMID: 37230509 No abstract available.
Editors' commentary.
Smith PEM, Fuller GN. Smith PEM, et al. Pract Neurol. 2023 Apr;23(2):103. doi: 10.1136/pn-2023-003740. Pract Neurol. 2023. PMID: 36941007 No abstract available.
Editors' commentary.
Smith PEM, Fuller GN. Smith PEM, et al. Pract Neurol. 2023 Oct;23(5):365. doi: 10.1136/pn-2023-003953. Pract Neurol. 2023. PMID: 37783485 No abstract available.
Editors' commentary.
Smith PEM, Fuller GN. Smith PEM, et al. Pract Neurol. 2023 Aug;23(4):269. doi: 10.1136/pn-2023-003878. Pract Neurol. 2023. PMID: 37507134 No abstract available.
Editors' commentary.
Smith PEM, Fuller GN. Smith PEM, et al. Pract Neurol. 2024 Mar 19;24(2):89. doi: 10.1136/pn-2024-004125. Pract Neurol. 2024. PMID: 38503450 No abstract available.
Editors' commentary.
Smith PEM, Fuller GN. Smith PEM, et al. Pract Neurol. 2024 Jan 23;24(1):1. doi: 10.1136/pn-2023-004077. Pract Neurol. 2024. PMID: 38262693 No abstract available.
Editors' commentary.
Smith PEM, Fuller GN. Smith PEM, et al. Pract Neurol. 2023 Feb;23(1):1. doi: 10.1136/pn-2022-003676. Pract Neurol. 2023. PMID: 36717204 No abstract available.
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Among authors: smith pe. Lancet. 2021 Apr 10;397(10282):1375-1386. doi: 10.1016/S0140-6736(21)00246-4. Lancet. 2021. PMID: 33838758 Free PMC article. Clinical Trial.
323 results